Company intelligence / Profile preview

RH Capital

San Francisco, California, USA

Ownership: Private
Development stage: Other

Overview

RH Capital invests in early-stage companies developing transformative innovations to improve outcomes, accessibility, and equity in women's health. Its portfolio includes 20+ startups across diagnostics, medical devices, therapeutics, digital health, and tech-enabled services, representing significant diversity and impact within the sector. 100% of its portfolio companies remain in business, with notable clinical and commercial progress among several marks-ups and exits.

Therapeutic areas: ImmunologyEndocrinologyCardiovascularOtherOncologyNeurologyWomen's Health
Modalities: Diagnostic deviceMedical deviceDigital health serviceDigital health deviceTherapeuticsTech-enabled services
Industry: Investors

Beyond the preview

Go deeper on RH Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RH Capital.

Explore the full profile